OneThree Biotech was born out of the largest precision medicine institute in America with the purpose of decreasing the failure rate of bringing therapeutics to market using biology driven artificial intelligence. Our technology was built in a lab setting; allowing us to engineer our methodologies around real-world results. While working with major biotech and pharma partners; we’ve validated our predictions through work in target discovery, compound and combination therapy identification, toxicity prediction, biomarker selection, and much more.
Our predictions have been validated with partners such as AstraZeneca, Jubilant, and more. For example, we predicted the top indication, and mechanism of action for Oncoceutics asset ONC201 which was subsequently validated in a Phase II trial.
Company Details
- Employees
- 7
- Founded
- -
- Address
- New York, 10037, Us
- in****@****ree.bio
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- onethree.bio
- Keywords
- Artificial Intelligence, Drug Discovery, Drug Development, Computational Biology, Machine Learning, Genetics.
- HQ
- New York
Onethree Biotech Questions
Onethree Biotech's website is onethree.bio
Onethree Biotech's LinkedIn profile is https://www.linkedin.com/company/onethree-biotech
Onethree Biotech has
7 employees.
View email and phone details for 7
employees at Onethree Biotech.
Onethree Biotech's industry is
Biotechnology Research
Onethree Biotech's top competitors are
Biotech Without Borders,
Accutar Biotech,
Biotia,
Sylentia Biotech,
Raven (Ra Ventures),
Biotech Xyz,
Anima Biotech,
Azure Biotech Inc.,
Cour Pharma,
Caspr Biotech.
Onethree Biotech's support email address is info@onethree.bio
Onethree Biotech's categories are Biotechnology Research
Onethree Biotech's founding year is 2018
